Investors

Insider Transactions

Date Name Title Type Shares Traded Sorted Ascending Price Range
Sep 9, 2013 landry robert e Officer Acquisition (Non Open Market) 5,000 n/a
Aug 5, 2015 mccorkle douglas s Officer Sell 5,000 585.51 - 586.00
Dec 17, 2012 mccorkle douglas s Officer Option Execute 5,000 16.80
Aug 5, 2015 mccorkle douglas s Officer Option Execute 5,000 270.43
Sep 9, 2013 schleifer leonard s Officer Automatic Buy 5,000 n/a
Sep 9, 2013 schleifer leonard s Officer Automatic Sell 5,000 275.04 - 277.12
May 13, 2010 shooter eric m Director Option Execute 5,000 25.43
Jun 9, 2010 sing george l Director Option Execute 5,000 25.43
Jul 26, 2012 sing george l Director Option Execute 5,000 18.80
Aug 22, 2012 sing george l Director Option Execute 5,000 18.80
Aug 23, 2012 sing george l Director Option Execute 5,000 18.80
May 27, 2015 sing george l Director Option Execute 5,000 19.69
May 10, 2013 sing george l Director Option Execute 5,000 15.01
May 18, 2010 sing george l Director Buy 5,000 28.44
May 27, 2015 sing george l Director Sell 5,000 515.00
May 10, 2013 sing george l Director Sell 5,000 270.00
Nov 29, 2012 sing george l Director Sell 5,000 185.00
Nov 16, 2012 sing george l Director Sell 5,000 152.00
Nov 13, 2012 sing george l Director Sell 5,000 148.00
Aug 22, 2012 sing george l Director Sell 5,000 139.00
Showing 341-360 of 1039 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)